Key facts
- segMedix’s last known valuation is $1.0M (Jul 2024).
- It has raised $140K; the latest was Early Stage VC in Oct 2025.
- Notable investors include US National Science Foundation, gener8tor, Maine Venture Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for segMedix
- ·The full record, as it builds
Funding rounds
No funding rounds for segMedix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About segMedix
Developer of a procurement-intelligence platform designed to streamline healthcare sourcing and decision-making for medical facilities. The company's platform offers AI-generated evaluation criteria, market-intelligence tools, contract-term generation, and supplier engagement features to streamline medical imaging through automated prostate analysis and reporting, enabling hospitals and healthcare procurement teams to make evidence-based purchasing decisions, save substantial time, and allocate resources more efficiently.
- Sector
- Healthcare
- HQ
- Fairport, NY, United States
- Founded
- 2024
- Employees
- 2
- Website
- segmedix.com/
- Ownership
- Privately Held (backing)
segMedix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in segMedix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on segMedix in its N-PORT filings yet. We sweep new filings monthly.